Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases

INTRODUCTION: The effect of nintedanib on slowing the rate of decline in forced vital capacity (FVC) has been investigated in randomized placebo-controlled trials in subjects with idiopathic pulmonary fibrosis (IPF), other progressive fibrosing interstitial lung diseases (ILDs), and ILD associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonella, Francesco, Cottin, Vincent, Valenzuela, Claudia, Wijsenbeek, Marlies, Voss, Florian, Rohr, Klaus B., Stowasser, Susanne, Maher, Toby M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239974/
https://www.ncbi.nlm.nih.gov/pubmed/35576048
http://dx.doi.org/10.1007/s12325-022-02145-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239974/
https://www.ncbi.nlm.nih.gov/pubmed/35576048
http://dx.doi.org/10.1007/s12325-022-02145-x

Ejemplares similares